Breaking News Instant updates and real-time market news.

TKPYY

Takeda Pharmaceutical

$24.68

-0.275 (-1.10%)

, SHPG

Shire

$156.43

2.91 (1.90%)

12:20
04/06/18
04/06
12:20
04/06/18
12:20

Takeda says CEO comments over Shire aligned with previous statements

Takeda Pharmaceutical (TKPYY) notes media reports about comments attributed to Takeda's CEO Christophe Weber regarding the company's possible offer for Shire (SHPG). Takeda confirms that Weber's comments were "aligned with the statements in the company's previous press releases." The company added, "As set out in the press releases 'Takeda Statement Regarding Shire plc' on March 28, 2018 in English and 'Takeda's official statement on Shire's stock fluctuation' on March 29, 2018 in Japanese, clearly defined strategic and financial objectives are core to Takeda's disciplined approach to acquisitions, including in relation to its dividend policy and credit rating, which are well-established. Any potential offer for Shire, if made, would have to align with this strict investment criteria."

TKPYY

Takeda Pharmaceutical

$24.68

-0.275 (-1.10%)

SHPG

Shire

$156.43

2.91 (1.90%)

  • 21

    Dec

TKPYY Takeda Pharmaceutical
$24.68

-0.275 (-1.10%)

03/29/18
JEFF
03/29/18
NO CHANGE
Target $172
JEFF
Buy
Shire investors may be amenable to $50B-plus bid, says Jefferies
With challenges in the hemophilia market near term, Shire (SHPG) investors could be amenable to another $50B-plus bid, similar to AbbVie's (ABBV) 2014 offer, Jefferies analyst David Steinberg tells investors in a research note. This would represent a 35% premium to Shire's recent near five-year low valuation, the analyst writes. He says "it remains to be seen" how Takeda Pharmaceutical (TKPYY) could structure a transaction for Shire given the companies' similar equity valuations. The analyst finds it possible that Takeda's disclosed interest could spark competitive bids from large cap pharma companies. He keeps a Buy rating on Shire with a $172 price target.
03/28/18
BOFA
03/28/18
NO CHANGE
BOFA
Buy
Still considerable value in Shire even in no Takeda bid scenario, says BofA/Merrill
BofA/Merrill analyst Graham Parry notes that Takeda (TKPYY) has said in a statement that it is considering an approach for Shire (SHPG) but that the consideration is at a preliminary and exploratory stage and no approach has been made to the board of Shire. The analyst continues to see considerable value in Shire with concerns over hemophilia more than priced into the stock and upsides from pipeline, notably SHP643 for HAE and SHP647 for Ulcerative colitis and Crohns, and the value of its plasma/immunology franchise overlooked. Even in a no bid scenario, Parry believes passage through hemophilia overhangs and increased awareness of the value in these assets should see Shire trade higher on 12-month view. He reiterates a Buy rating on Shire's shares.
01/16/18
BTIG
01/16/18
DOWNGRADE
BTIG
Neutral
TiGenix downgraded at BTIG to Neutral on valuation
As noted earlier, BTIG analyst Timothy Chiang downgraded TiGenix (TIG) to Neutral from Buy, saying the run-up of 81% year to date in the stock price has exceeded his target and warrants a move to the sidelines. Chiang believes that the acquisition offer by Takeda (TKPYY) will pass the required regulatory review of TiGenix lead product Alofisei in the E.U., adding that there is now less than 5% difference in the stock price relative to the Takeda offer.
10/03/17
JMPS
10/03/17
NO CHANGE
Target $25
JMPS
Outperform
Myovant Phase 3 results further de-risk ongoing trials, says JMP Securities
After Myovant Sciences (MYOV) and partner Takeda (TKPYY) announced a Japanese study evaluating the efficacy and safety of relugolix to treat uterine fibroids met its primary endpoint, JMP Securities analyst Jason Butler said the results represent a "best case outcome" and have a clear positive read through to ongoing international Phase 3 trials in uterine fibroids and endometriosis. The analyst, who increased his view of the probability of success in UF and EM, raised his price target on Myovant shares to $25 from $23 and keeps an Outperform rating on the stock.
SHPG Shire
$156.43

2.91 (1.90%)

03/07/18
HCWC
03/07/18
NO CHANGE
Target $12
HCWC
Buy
Caladrius price target raised to $12 from $7 at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju raised his price target for Caladrius Biosciences (CLBS) to $12 after the company acquired from Shire (SHPG) an exclusive worldwide license to data and regulatory filings for a late-stage CD34+ cell therapy program for the treatment of chronic myocardial ischemia targeting refractory angina. The deal "significantly enriches" Caladrius' existing pipeline and should provide an "additional attractive shot on goal" in the coming years, Selvaraju tells investors in a research note. He increased his valuation of the company to $120M from $60M and reiterates a Buy rating on the shares.
02/22/18
BOFA
02/22/18
NO CHANGE
BOFA
Buy
Shire post results weakness overdone, says BofA/Merrill
BofA/Merrill analyst Graham Parry believes Shire post results weakness is overdone and says shares remain undervalued. The analyst argued that cons EPS cuts are already priced in, and reiterates a Buy rating on the shares.

TODAY'S FREE FLY STORIES

VIPS

Vipshop

$7.97

-1.015 (-11.30%)

09:47
08/14/18
08/14
09:47
08/14/18
09:47
Hot Stocks
Vipshop falls -11.6% »

Vipshop is down -11.6%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 10

    Sep

HUYA

HUYA

$28.05

-4.81 (-14.64%)

09:47
08/14/18
08/14
09:47
08/14/18
09:47
Hot Stocks
HUYA falls -14.4% »

HUYA is down -14.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWCH

Switch

$10.47

-3.49 (-25.00%)

09:47
08/14/18
08/14
09:47
08/14/18
09:47
Hot Stocks
Switch falls -25.1% »

Switch is down -25.1%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YUMC

Yum China

$36.25

2.03 (5.93%)

09:47
08/14/18
08/14
09:47
08/14/18
09:47
Hot Stocks
Yum China rises 6.1% »

Yum China is up 6.1%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

AAP

Advance Auto Parts

$153.90

9.11 (6.29%)

09:47
08/14/18
08/14
09:47
08/14/18
09:47
Hot Stocks
Advance Auto Parts rises 6.6% »

Advance Auto Parts is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

TPR

Tapestry

$51.19

3.77 (7.95%)

09:47
08/14/18
08/14
09:47
08/14/18
09:47
Hot Stocks
Tapestry rises 7.8% »

Tapestry is up 7.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 12

    Sep

AAP

Advance Auto Parts

$144.79

(0.00%)

09:44
08/14/18
08/14
09:44
08/14/18
09:44
Technical Analysis
Technical Take: Advance Auto Parts at new 52-week high after earnings »

In early trading the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

FB

Facebook

$180.08

(0.00%)

, BABA

Alibaba

$177.65

(0.00%)

09:44
08/14/18
08/14
09:44
08/14/18
09:44
Hot Stocks
Jana Partners buys Facebook and Alibaba in Q2, sells out of Northrop »

Barry Rosenstein's…

FB

Facebook

$180.08

(0.00%)

BABA

Alibaba

$177.65

(0.00%)

MSFT

Microsoft

$108.24

(0.00%)

WFC

Wells Fargo

$57.64

(0.00%)

GOOGL

Alphabet Class A

$1,248.76

(0.00%)

GOOG

Alphabet

$1,235.10

(0.00%)

BLMN

Bloomin' Brands

$18.13

(0.00%)

NOC

Northrop Grumman

$292.10

(0.00%)

KDP

Keurig Dr Pepper

$23.75

(0.00%)

WRK

WestRock

$54.73

(0.00%)

CI

Cigna

$181.78

(0.00%)

EA

Electronic Arts

$131.29

(0.00%)

A

Agilent

$65.95

(0.00%)

AAPL

Apple

$208.87

(0.00%)

TIF

Tiffany

$130.88

(0.00%)

LRCX

Lam Research

$178.13

(0.00%)

HDS

HD Supply

$43.72

(0.00%)

ADSK

Autodesk

$133.41

(0.00%)

BSX

Boston Scientific

$33.30

(0.00%)

ZBH

Zimmer Biomet

$122.45

(0.00%)

JACK

Jack in the Box

$89.03

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 15

    Aug

  • 15

    Aug

  • 19

    Aug

  • 20

    Aug

  • 21

    Aug

  • 21

    Aug

  • 22

    Aug

  • 23

    Aug

  • 23

    Aug

  • 23

    Aug

  • 24

    Aug

  • 28

    Aug

  • 04

    Sep

  • 10

    Sep

  • 11

    Sep

  • 12

    Sep

  • 12

    Sep

  • 12

    Sep

  • 13

    Sep

  • 18

    Sep

  • 28

    Oct

  • 06

    Nov

  • 12

    Apr

  • 13

    Jul

  • 15

    Oct

F

Ford

$9.46

(0.00%)

, BABA

Alibaba

$177.65

(0.00%)

09:42
08/14/18
08/14
09:42
08/14/18
09:42
Hot Stocks
Ford-owned Autonomic announces partnership with Alibaba Cloud »

Autonomic, a wholly owned…

F

Ford

$9.46

(0.00%)

BABA

Alibaba

$177.65

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 23

    Aug

  • 31

    Aug

  • 10

    Sep

CMI

Cummins

$139.70

(0.00%)

, BZUN

Baozun

$52.66

(0.00%)

09:40
08/14/18
08/14
09:40
08/14/18
09:40
Options
Unusually active option classes on open August 14th »

Unusual total active…

CMI

Cummins

$139.70

(0.00%)

BZUN

Baozun

$52.66

(0.00%)

TPR

Tapestry

$47.42

(0.00%)

HD

Home Depot

$194.11

(0.00%)

SWN

Southwestern Energy

$5.34

(0.00%)

NWL

Newell Brands

$20.47

(0.00%)

XLE

Energy Select Sector SPDR

$74.30

(0.00%)

FXI

iShares China Large-Cap ETF

$42.15

(0.00%)

M

Macy's

$40.08

(0.00%)

BABA

Alibaba

$177.65

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 15

    Aug

  • 23

    Aug

  • 10

    Sep

  • 12

    Sep

  • 17

    Sep

09:40
08/14/18
08/14
09:40
08/14/18
09:40
General news
U.S. corporate bond update: issuance remains solid »

U.S. corporate bond…

DB

Deutsche Bank

$11.44

-0.375 (-3.17%)

09:39
08/14/18
08/14
09:39
08/14/18
09:39
Periodicals
Deutsche Bank to review contract of IB head Ritchie in Oct., Financial News says »

Deutsche Bank will review…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYNL

Synalloy

$23.55

(0.00%)

09:39
08/14/18
08/14
09:39
08/14/18
09:39
Hot Stocks
Breaking Hot Stocks news story on Synalloy »

Synalloy trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

SWCH

Switch

$13.96

-0.11 (-0.78%)

09:36
08/14/18
08/14
09:36
08/14/18
09:36
Recommendations
Switch analyst commentary  »

Switch price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HD

Home Depot

$194.11

-2.19 (-1.12%)

09:35
08/14/18
08/14
09:35
08/14/18
09:35
Hot Stocks
Breaking Hot Stocks news story on Home Depot »

Home Depot says tariff…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

F

Ford

$9.46

-0.275 (-2.82%)

09:33
08/14/18
08/14
09:33
08/14/18
09:33
Periodicals
Ford recalls nearly 4,000 cars in Russia, Reuters reports »

Ford is recalling 3,968…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 31

    Aug

CPT

Camden Property

$92.39

-0.01 (-0.01%)

09:31
08/14/18
08/14
09:31
08/14/18
09:31
Recommendations
Camden Property analyst commentary  »

Camden Property price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

09:30
08/14/18
08/14
09:30
08/14/18
09:30
General news
Stocks open higher as Turkey concerns ease »

Stock futures traded…

ABIL

Ability

$5.95

1.38 (30.20%)

09:30
08/14/18
08/14
09:30
08/14/18
09:30
Syndicate
Ability announces $3.35M registered direct offering »

Ability announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:30
08/14/18
08/14
09:30
08/14/18
09:30
General news
The U.S. July trade price report was weak »

The U.S. July trade price…

TPR

Tapestry

$47.42

-0.52 (-1.08%)

09:29
08/14/18
08/14
09:29
08/14/18
09:29
Hot Stocks
Tapestry expects 'modest' net decrease in Coach brand stores in FY19 »

Says will continue to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 12

    Sep

DHT

DHT Holdings

$4.31

-0.015 (-0.35%)

09:29
08/14/18
08/14
09:29
08/14/18
09:29
Downgrade
DHT Holdings rating change  »

DHT Holdings downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

ABIL

Ability

$5.95

1.38 (30.20%)

09:28
08/14/18
08/14
09:28
08/14/18
09:28
Syndicate
Ability announces registered direct offering »

Ability Inc. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGEN

Tecogen

$3.33

0.03 (0.91%)

09:25
08/14/18
08/14
09:25
08/14/18
09:25
Hot Stocks
Tecogen receives U.S. patent for catalyst formulation for Ultera emissions »

Tecogen has been granted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

MAR

Marriott

$120.48

0.23 (0.19%)

09:25
08/14/18
08/14
09:25
08/14/18
09:25
Upgrade
Marriott rating change  »

Marriott upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.